Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 2889-2898

  Kristrom B ^a,b,c   Jansson, C ^b   Rosberg, S ^b   Albertsson Wikland, K ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CHILD; CHILD GROWTH; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SHORT STATURE;

ADOLESCENT; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MULTIVARIATE ANALYSIS; OSMOLAR CONCENTRATION; TIME FACTORS;

EID: 0030885022     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.2889     Document Type: Article

References (34)

1. Lee P, Wilson D, Rountree L, Hintz R, Rosenfeld R. 1490 Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing. Pediatr Res. 27:45-51.
2. Hindmarsh P, Smith PJ, Brook CGD, Matthews DR. 1987 The relationship between height velocity and growth hormone secretion in short prepubertal children. Clin Endocrinol (Oxf). 27:581-591.
3. Albertsson-Wikland K, Hall K. 1987 Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels. J Clin Endocrinol Metab. 65:671-678.
4. Schwartz D, Hu C-S, Shulman D, Root A, Bercu B. 1990 Linear growth response to exogenous growth hormone in children with short stature. Am J Dis Child. 144:1092-1097.
5. Moore K, Donaldsson D, Ideus P, Gifford R, Moore V. 1993 Clinical diagnosis of children with extremely short stature and their response to growth hormone. J Pediatr. 122:687-692.
6. Cacciari E, Tassoni P, Cicognani A, et al. 1994 Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. J Clin Endocrinol Metab. 79:1663-1669.
7. Allen D, Brook C, Bridges N, Hindmarsh P, Guyda H, Frazier D. 1994 Therapeutic controversies: growth hormone (GH) treatment of non-GH deficient subjects. J Clin Endocrinol Metab. 79:1239-1240.
8. Wit J, Boersma B, Muinck Keizer-Schrama S, et al. 1995 Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Clin Endocrinol (Oxf). 42:365-372.
9. Laron Z. 1995 Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab. 80:1526-1531.
10. Blethen S, Compton P, Lippe B, Rosenfeld R, August G, Johansson A. 1993 Factors predicting the response to growth hormone (GH) therapy in children with GH deficiency. J Clin Endocrinol Metab. 76:574-579.
11. Spagnoli A, Spadoni GL, Cianfarani S, Pasquino AM, Troiani S, Boscherini B. 1995 Prediction of the outcome of growth hormone therapy in children with idiopatic short stature. J Pediatr. 126:905-909.
12. Kriström B, Karlberg J, Albertsson-Wikland K. 1995 Prediction of the growth response of short prepubertal children treated with growth hormone. Acta Paediatr Scand. 84:51-57.
13. Jackson Smith W, Nam T, Underwood L, Busby W, Celnicker A, Clemmons D. 1993 Use of insulin-like growth factor-binding protein-2 (IGFBP2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab. 77:1294-1299.
14. Thalange N, Price D, Gill M, Whatmore A, Addison G, Clayton P. 1996 Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity. Pediatr Res. 39:849-855.
15. Niklasson N, Ericson A, Fryer J, Karlberg J, Lawrence C, Karlberg P. 1991 An update of the Swedish reference standards for birth for weight, length, and head circumference at birth for given gestational age (1977-81). Acta Paediatr Scand. 80:756-762.
16. Karlberg J. 1989 On the construction of the infant-childhood-puberty growth standard. Acta Paediatr Scand. 356(Suppl):26-37.
17. Karlberg P, Taranger J, Engström I, Lichtenstein H, Svennberg-Redegren I. 1976 The somatic development of children in a Swedish urban community. Acta Paediatr Scand. 258(Suppl):7-76.
18. Karlberg J, Albertsson-Wikland K. 1996 Recent developments in infant nutrition. In: Bindels JG, Goedhardt AC, Visser HKA, eds. : Kluwer; 112-127.
19. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T. 1994 Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab. 78:1195-1201.
20. Boguszewski M, Rosberg S, Albertsson-Wikland K. 1995 Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational children age children. J Clin Endocrinol Metab. 80:2599-2606.
21. Blum WF, Breier BH. 1994 Radioimmunoassays for IGFs and IGHBPs. Growth Regul. 4:11-19.
22. Juul A, Dalgaard F, Blum W, et al. 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-1, ICF-II, IGFBP-1, ICFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 80:2534-2542.
23. Jansson C, Andersson E, Rosberg S, Albertsson-Wikland K. Proc of the 10th Int Congr of Endocrinol. 1996;P3-P49.
24. Bradley J. 1968 Distribution of free statistical tests. London. Prentice-Hall; 68-86.
25. Gelander L, Albertsson-Wikland K. 1989 Growth hormone (GH) release after administration of GH-releasing hormone to endogenous 24-h GH secretion in short children. J Endocrinol. 122:61-68.
26. Rosenfeld RG. 1997 Editorial: Is growth hormone deficiency a viable diagnosis? J Clin Endocrinol Metab. 82:349-351.
27. Blum W, Ranke M. 1990 Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders. Horm Res. 33:31-37.
28. Albertsson-Wikland K, Westphal O, Westgren U. 1986 Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand. 75:89-97.
29. MacGillivray M, Baptista J, Johanson A. 1996 Outcome of a four-year randomized study of daily vs. three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Genentech Study Group. J Clin Endocrinol Metab. 81:1806-1809.
30. Ranke M, Guilbaud O. 1991 Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study. Acta Paediatr Scand. 379(Suppl):109-115.
31. Ranke M, Guilbaud O, Lindberg A, Cole T. 1993 Prediction of the growth response in children with various growth disorders treated with growth hormone: analysis of data from the Kabi Pharmacia International Growth Study. Acta Paediatr. 391(Suppl):82-88.
32. Goddard A, Covello R, Luoh S-M, et al. 1995 Mutations of the growth hormone receptor in Children with idiopatic short stature. N Engl J Med. 333:1093-1098.
33. Savage M, Woods K. 1996 The investigation of growth hormone insensitivity. Clin Endocrinol (Oxf). 45:257-260.
34. Attie M, Carlsson L, Rundle A, Sherman B. 1995 Evidence for partial growth hormone insensitivity among patients with idiopatic short stature. J Pediatr. 127:244-250.